Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North America company, Frenova manages a networked system of clinical research assets and resources including over 450 principal investigators at more than 260 sites representing 160 medical practices. Frenova manages clinical trials in kidney disease and its adjacent disease areas and medical conditions. Frenova also offers clinical trial sponsors access to nearly 200,000 active end stage renal disease patients and hundreds of thousands of active chronic kidney disease patients. For more information, visit www.FrenovaRenalResearch.com.
http://www.frenovarenalresearch.com/